Outpatient venetoclax initiation following obinutuzumab debulking in patients with high or medium tumor burden at baseline
- DOI
- 10.1080/10428194.2026.2748719
- Published
- 2026-11-02
- Container
- Leukemia & Lymphoma
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/10428194.2026.2748719,
title = {Outpatient venetoclax initiation following obinutuzumab debulking in patients with high or medium tumor burden at baseline},
author = {Jeff P. Sharman and David Andorsky and Jason Melear and Sudhir Manda and Bertrand Anz and Habte Yimer and John M. Burke and Suzanne Fanning and Jay Courtright and Suman Kambhampati and Zhuangzhuang Liu and Brenda Chyla and Wendy Sinai and Ian Flinn},
year = {2026},
journal = {Leukemia \& Lymphoma},
doi = {10.1080/10428194.2026.2748719},
url = {https://doi.org/10.1080/10428194.2026.2748719}
}RIS
TY - JOUR TI - Outpatient venetoclax initiation following obinutuzumab debulking in patients with high or medium tumor burden at baseline AU - Jeff P. Sharman AU - David Andorsky AU - Jason Melear AU - Sudhir Manda AU - Bertrand Anz AU - Habte Yimer AU - John M. Burke AU - Suzanne Fanning AU - Jay Courtright AU - Suman Kambhampati AU - Zhuangzhuang Liu AU - Brenda Chyla AU - Wendy Sinai AU - Ian Flinn PY - 2026 JO - Leukemia & Lymphoma DO - 10.1080/10428194.2026.2748719 UR - https://doi.org/10.1080/10428194.2026.2748719 ER -
APA
Sharman, J. P., Andorsky, D., Melear, J., Manda, S., Anz, B., Yimer, H., Burke, J. M., Fanning, S., Courtright, J., Kambhampati, S., Liu, Z., Chyla, B., Sinai, W., & Flinn, I. (2026). Outpatient venetoclax initiation following obinutuzumab debulking in patients with high or medium tumor burden at baseline. Leukemia & Lymphoma. https://doi.org/10.1080/10428194.2026.2748719
Source records
- crossref · retrieved 2026-11-05T07:32:57.281Z